Initiate the BB-301 pivotal trial

Deadline not yet reached (246 days left)

What the company said

“Benitec anticipates initiating the BB-301 pivotal trial in mid-2027.”

SourceBenitec Biopharma Inc. Form 8-K press release, 2026-09-14
FilingSEC filing index
Deadline as statedmid-2027
Deadline used30 Jun 2027, the last day of the stated period
TypeProject
Permanent referenceKI-C-2026-BNTC-000674
Cite as https://keptindex.org/c/KI-C-2026-BNTC-000674/ — this address never changes.

The deadline has not passed yet, so there is nothing to check. We look for evidence starting 30 days after 30 Jun 2027.

Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.

Version 1 · original · stated 14 Sep 2026

Deadline 30 Jun 2027 (“mid-2027”) · wording expected
Version 2 · stated 5 Oct 2026

Deadline 30 Jun 2027 (“mid-2027”) · wording firm

“The BB-301 pivotal trial remains on track to begin in mid-2027”
Source for this version

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.

Are you Benitec Biopharma Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.